Profound Medical (NASDAQ:PROF; TSX:PRN) announced that it will unveil its third TULSA-AI software module, UA Alignment Assistant at the upcoming 110th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA 2024) being held in Chicago, IL, December 1-4, 2024, and the 25th Annual Meeting of the Society of Urologic Oncology (SUO 2024) taking place in Dallas, TX, December 4 – 6, 2024.
This tool is designed to streamline the alignment of the ultrasound applicator (UA) catheter that resides in the center of the prostate during the TULSA procedure, performed using Profound’s TULSA-PRO system. The primary benefit of the software is improvement in workflow consistency, as instead of aligning the AU catheter manually, it will now be done the same way every time via the module.
The TULSA procedure has the potential of becoming a mainstream treatment modality across the entire prostate disease spectrum; ranging from low-, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and benign prostatic hyperplasia (BPH); to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. TULSA employs real-time MR guidance for precision to preserve patients’ urinary continence and sexual function, while killing the targeted prostate tissue via precise sound absorption technology that gently heats it to 55-57°C. TULSA is an incision- and radiation-free “one-and-done” procedure performed in a single session that takes a few hours. Virtually all prostate shapes and sizes can be safely, effectively, and efficiently treated with TULSA. There is no bleeding associated with the procedure; no hospital stay is required; and most TULSA patients report quick recovery to their normal routine.
In a statement, Arun Menawat, Ph.D., CEO and Chairman of Profound Medical, said, “One of the focusses of RSNA 2024 – which is expected to attract more than 40,000 physicians, researchers and industry participants – will be on the increasingly important role that AI can play in improving the efficiency and quality of care.” He continued, “it is the ideal forum for us to unveil for the first time our third TULSA-AI module, UA Alignment Assistant.”
Dr. Menawat also noted that the RSNA 2024 and SUO 2024 meetings will feature presentations on the TULSA procedure by physicians and researchers from the Busch Center, UT Southwestern Medical Center and the Mayo Clinic.
